When is it safe to stop Pneumocystis jiroveci pneumonia prophylaxis? Insights from three cases complicating autoimmune diseases

Arthritis Rheum. 2008 Jul 15;59(7):1034-9. doi: 10.1002/art.23822.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Anti-Infective Agents / administration & dosage*
  • Anti-Inflammatory Agents / adverse effects
  • Antibiotic Prophylaxis / methods*
  • Autoimmune Diseases / complications
  • Autoimmune Diseases / drug therapy
  • Autoimmune Diseases / immunology*
  • CD4 Lymphocyte Count
  • Drug Administration Schedule
  • Female
  • Humans
  • Immunocompromised Host*
  • Male
  • Middle Aged
  • Pneumocystis carinii* / immunology
  • Pneumonia, Pneumocystis / complications
  • Pneumonia, Pneumocystis / immunology
  • Pneumonia, Pneumocystis / prevention & control*

Substances

  • Anti-Infective Agents
  • Anti-Inflammatory Agents